Aladja, Salma A.
HRN: 19-31-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2023
CEFTRIAXONE 1G (VIAL)
01/12/2023
01/18/2023
IVT
2 G
Once A Day
Community Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes